FNY Investment Advisers’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$48K	Buy	+2,407	New	+$48K	0.02%	404
2020 Q4	–	Sell	-2,000	Closed	-$29K	–	724
2020 Q3	$29K	Buy	+2,000	New	+$29K	0.01%	272